Holen Sie sich die Stockscreener-App
22.74
0.98%
0.22
Handel nachbörslich:
22.50
-0.24
-1.06%
Schlusskurs vom Vortag:
$22.52
Offen:
$22.6
24-Stunden-Volumen:
582.02K
Relative Volume:
0.81
Marktkapitalisierung:
$1.68B
Einnahmen:
$425.13M
Nettoeinkommen (Verlust:
$271.17M
KGV:
7.4428
EPS:
3.0553
Netto-Cashflow:
$195.80M
1W Leistung:
+0.40%
1M Leistung:
-4.29%
6M Leistung:
+2.06%
1J Leistung:
+22.19%
1-Tages-Spanne:
$22.53
$23.20
1-Wochen-Bereich:
$22.20
$23.99
52-Wochen-Spanne:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
22.74 | 1.66B | 425.13M | 271.17M | 195.80M | 3.0553 |
VRTX
Vertex Pharmaceuticals Inc
|
448.29 | 110.45B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
723.41 | 74.73B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
812.81 | 50.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
292.03 | 38.03B | 4.29B | 577.22M | 641.34M | 4.2086 |
ONC
Beone Medicines Ltd Adr
|
315.07 | 32.24B | 5.76B | 514.49M | 1.10B | 4.4813 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-17 | Eingeleitet | BTIG Research | Buy |
| 2025-09-30 | Eingeleitet | Goldman | Sell |
| 2025-08-11 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Eingeleitet | Goldman | Neutral |
| 2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Innoviva Inc Aktie (INVA) Neueste Nachrichten
TradingKey - TradingKey
Why are smart money investors paying attention to Innoviva (INVA)? (Mini Rally) 2026-05-11Professional Trade Ideas - newser.com
Is Innoviva (INVA) Pricing Look Compelling After Recent Share Price Softness? - Yahoo Finance
What Innoviva (INVA)'s Profit Rebound and ESOP Share Filing Means For Shareholders - simplywall.st
Innoviva Inc Emerges as Top Small Cap Value Stock with High Royalty Revenues - HarianBasis.co
Innoviva, Inc. (INVA) Draws Bullish View from Cantor on Recurring Royalty Strength - Yahoo Finance
Innoviva (INVA) Q1 Profit Swing Challenges Bearish Earnings Decline Narratives - Sahm
INVA SEC FilingsInnoviva 10-K, 10-Q, 8-K Forms - Stock Titan
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $42 - Moomoo
MSN Money - MSN
Innoviva: Q1 Earnings Snapshot - theheraldreview.com
Innoviva Reports First Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva (INVA) Tops Q1 Earnings Estimates - Yahoo Finance
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Innoviva (INVA) grants RSUs and stock options to director Haimovitz - Stock Titan
Earnings Flash (INVA) Innoviva, Inc. Reports Q1 Revenue $98.0M, vs. FactSet Est of $101.6M - marketscreener.com
[10-Q] Innoviva, Inc. Quarterly Earnings Report - Stock Titan
Innoviva (NASDAQ: INVA) posts strong Q1 2026 profit on investment gains - Stock Titan
Innoviva (INVA) CEO receives new RSU and stock option grants - Stock Titan
Innoviva (INVA) awards RSUs and stock options to accounting chief - Stock Titan
Innoviva (NASDAQ: INVA) director receives RSUs and 10,000 stock options - Stock Titan
[Form 4] Innoviva, Inc. Insider Trading Activity - Stock Titan
Innoviva (NASDAQ: INVA) director granted RSUs and 10,000 stock options - Stock Titan
Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What Innoviva (INVA) does that builds long term value | Q4 2025: Better Than ExpectedBrand Strength - newser.com
Innoviva Inc (INVA) - MSN
Innoviva, Inc. 8-K SEC Filing – Company Information, Address, and Stock Details for May 2026 - Minichart
Innoviva Shareholders Back Directors, Pay Plan and Incentives - TipRanks
Innoviva (NASDAQ: INVA) holders approve board, pay and 2026 equity plan - Stock Titan
Hussman Strategic Advisors Inc. Boosts Stock Position in Innoviva, Inc. $INVA - MarketBeat
Technical Reactions to INVA Trends in Macro Strategies - Stock Traders Daily
Universal Beteiligungs und Servicegesellschaft mbH Grows Stock Holdings in Innoviva, Inc. $INVA - MarketBeat
[SCHEDULE 13G] Innoviva, Inc. Passive Investment Disclosure (>5%) - Stock Titan
Innoviva (INVA) to Release Quarterly Earnings on Wednesday - MarketBeat
INVA (Innoviva) Q4 2025 earnings per share far outpace analyst estimates, shares tick higher in today’s trading.Community Breakout Alerts - newser.com
Trading the Move, Not the Narrative: (INVA) Edition - Stock Traders Daily
Innoviva, Inc. (NASDAQ:INVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
INVA Technical Analysis & Stock Price Forecast - Intellectia AI
Innoviva (NASDAQ:INVA) Shares Cross Above 200-Day Moving AverageTime to Sell? - MarketBeat
AI Stocks: Will Innoviva Inc stock hit new highs in YEAR2026 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Trade Recap: Will Innoviva Inc outperform tech stocks2026 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Earnings Recap: Will Innoviva Inc benefit from sector rotation2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn
(INVA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aug Summary: Is Innoviva Inc likely to announce a buyback2026 Technicals & Fast Entry and Exit Trade Plans - baoquankhu1.vn
3 Bargain-Cheap Small Caps Worth a Second Look - Investing.com
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Nuvalent (NUVL) and Innoviva (INVA) - The Globe and Mail
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo Finance
Buybacks Report: Is Innoviva Inc likely to announce a buybackProfit Target & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Cantor Fitzgerald reiterates Innoviva stock rating on royalty strength By Investing.com - Investing.com Australia
Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):